Anavex Life Sciences Corp (STU:12X1)
€ 11.68 2.842 (32.16%) Market Cap: 985.54 Mil Enterprise Value: 858.70 Mil PE Ratio: 0 PB Ratio: 8.54 GF Score: 41/100

Q4 2021 Anavex Life Sciences Corp Earnings Call Transcript

Nov 24, 2021 / 09:30PM GMT
Release Date Price: €16.7 (-2.91%)
Operator

Welcome to the Anavex Life Sciences Fiscal 2021 Fourth Quarter Conference Call. My name is Adrianne, and I'll be your operator for today's call. (Operator Instructions)

Please note, this conference call is being recorded.

I'll now turn the call over to your host, Clint Tomlinson. Clint, sir, you may begin.

Clint Tomlinson
Anavex Life Sciences Corp. - VP of Corporate

Thank you, and good afternoon, everyone. We appreciate you joining us today for Anavex Life Sciences' Fourth Quarter Conference Call to review financial results and discuss the company's business updates. A taped replay of this call will be available after the call, and the call will also be available for replay on Anavex's website at www.anavex.com.

With us today is Dr. Christopher Missling, President and Chief Executive Officer; and Sandra Boenisch; Principal Financial Officer.

Following management's remarks, there will be a question-and-answer session. Before we begin, please note this -- that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot